nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—CYP1A2—Carmustine—malignant glioma	0.276	0.57	CbGbCtD
Propranolol—CYP3A4—Temozolomide—malignant glioma	0.209	0.431	CbGbCtD
Propranolol—HTR1B—dura mater—malignant glioma	0.0533	0.341	CbGeAlD
Propranolol—ORM1—vertebral column—malignant glioma	0.0171	0.109	CbGeAlD
Propranolol—HTR1B—telencephalic ventricle—malignant glioma	0.0133	0.085	CbGeAlD
Propranolol—HTR1A—telencephalic ventricle—malignant glioma	0.0107	0.0686	CbGeAlD
Propranolol—HTR1B—blood vessel—malignant glioma	0.00658	0.0421	CbGeAlD
Propranolol—Carvedilol—GJA1—malignant glioma	0.00548	0.329	CrCbGaD
Propranolol—Myopathy—Temozolomide—malignant glioma	0.0044	0.0399	CcSEcCtD
Propranolol—Carvedilol—HIF1A—malignant glioma	0.00415	0.25	CrCbGaD
Propranolol—HTR1B—brainstem—malignant glioma	0.0036	0.023	CbGeAlD
Propranolol—HTR1B—telencephalon—malignant glioma	0.00319	0.0204	CbGeAlD
Propranolol—ADRB1—telencephalon—malignant glioma	0.003	0.0192	CbGeAlD
Propranolol—HTR1A—brainstem—malignant glioma	0.0029	0.0186	CbGeAlD
Propranolol—Dry eye—Temozolomide—malignant glioma	0.00285	0.0259	CcSEcCtD
Propranolol—HTR1A—telencephalon—malignant glioma	0.00257	0.0165	CbGeAlD
Propranolol—Vascular purpura—Temozolomide—malignant glioma	0.0025	0.0227	CcSEcCtD
Propranolol—Amnesia—Carmustine—malignant glioma	0.00247	0.0224	CcSEcCtD
Propranolol—ORM1—spinal cord—malignant glioma	0.00238	0.0153	CbGeAlD
Propranolol—Amnesia—Temozolomide—malignant glioma	0.00238	0.0216	CcSEcCtD
Propranolol—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00237	0.0215	CcSEcCtD
Propranolol—Purpura—Temozolomide—malignant glioma	0.00232	0.0211	CcSEcCtD
Propranolol—HTR1B—midbrain—malignant glioma	0.00229	0.0147	CbGeAlD
Propranolol—HTR1B—spinal cord—malignant glioma	0.00224	0.0143	CbGeAlD
Propranolol—Affect lability—Temozolomide—malignant glioma	0.0022	0.02	CcSEcCtD
Propranolol—Mood swings—Temozolomide—malignant glioma	0.00212	0.0193	CcSEcCtD
Propranolol—ABCB1—blood vessel—malignant glioma	0.00207	0.0133	CbGeAlD
Propranolol—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00202	0.0183	CcSEcCtD
Propranolol—ORM1—central nervous system—malignant glioma	0.00193	0.0124	CbGeAlD
Propranolol—Neutropenia—Carmustine—malignant glioma	0.00187	0.017	CcSEcCtD
Propranolol—Bronchitis—Temozolomide—malignant glioma	0.00186	0.0169	CcSEcCtD
Propranolol—HTR1A—midbrain—malignant glioma	0.00185	0.0118	CbGeAlD
Propranolol—HTR1B—central nervous system—malignant glioma	0.00181	0.0116	CbGeAlD
Propranolol—Neutropenia—Temozolomide—malignant glioma	0.00181	0.0164	CcSEcCtD
Propranolol—HTR1A—spinal cord—malignant glioma	0.0018	0.0115	CbGeAlD
Propranolol—Terbinafine—PTGS1—malignant glioma	0.00179	0.108	CrCbGaD
Propranolol—Erectile dysfunction—Temozolomide—malignant glioma	0.00178	0.0162	CcSEcCtD
Propranolol—Depression—Carmustine—malignant glioma	0.00178	0.0162	CcSEcCtD
Propranolol—Duloxetine—SLC6A3—malignant glioma	0.00175	0.105	CrCbGaD
Propranolol—Infestation—Temozolomide—malignant glioma	0.00173	0.0157	CcSEcCtD
Propranolol—Infestation NOS—Temozolomide—malignant glioma	0.00173	0.0157	CcSEcCtD
Propranolol—Depression—Temozolomide—malignant glioma	0.00172	0.0156	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00171	0.0155	CcSEcCtD
Propranolol—ADRB1—central nervous system—malignant glioma	0.00171	0.0109	CbGeAlD
Propranolol—Carvedilol—VEGFA—malignant glioma	0.00167	0.101	CrCbGaD
Propranolol—Hallucination—Carmustine—malignant glioma	0.0016	0.0145	CcSEcCtD
Propranolol—CYP2D6—brainstem—malignant glioma	0.00158	0.0101	CbGeAlD
Propranolol—Visual impairment—Carmustine—malignant glioma	0.00155	0.014	CcSEcCtD
Propranolol—Hallucination—Temozolomide—malignant glioma	0.00154	0.014	CcSEcCtD
Propranolol—Pharyngitis—Temozolomide—malignant glioma	0.00154	0.014	CcSEcCtD
Propranolol—Visual impairment—Temozolomide—malignant glioma	0.00149	0.0135	CcSEcCtD
Propranolol—Erythema multiforme—Temozolomide—malignant glioma	0.00147	0.0133	CcSEcCtD
Propranolol—HTR1A—central nervous system—malignant glioma	0.00146	0.00936	CbGeAlD
Propranolol—HTR1B—brain—malignant glioma	0.00144	0.00921	CbGeAlD
Propranolol—Cardiac disorder—Temozolomide—malignant glioma	0.00144	0.013	CcSEcCtD
Propranolol—HTR1A—cerebellum—malignant glioma	0.00143	0.00915	CbGeAlD
Propranolol—Alopecia—Carmustine—malignant glioma	0.00142	0.0129	CcSEcCtD
Propranolol—Mental disorder—Carmustine—malignant glioma	0.0014	0.0127	CcSEcCtD
Propranolol—CYP2D6—telencephalon—malignant glioma	0.0014	0.00894	CbGeAlD
Propranolol—Erythema—Carmustine—malignant glioma	0.0014	0.0127	CcSEcCtD
Propranolol—Alopecia—Temozolomide—malignant glioma	0.00137	0.0124	CcSEcCtD
Propranolol—Mental disorder—Temozolomide—malignant glioma	0.00136	0.0123	CcSEcCtD
Propranolol—ADRB1—brain—malignant glioma	0.00135	0.00866	CbGeAlD
Propranolol—Erythema—Temozolomide—malignant glioma	0.00135	0.0122	CcSEcCtD
Propranolol—Agitation—Carmustine—malignant glioma	0.00128	0.0116	CcSEcCtD
Propranolol—Agitation—Temozolomide—malignant glioma	0.00124	0.0112	CcSEcCtD
Propranolol—ABCB1—embryo—malignant glioma	0.00124	0.00791	CbGeAlD
Propranolol—Vertigo—Temozolomide—malignant glioma	0.00121	0.011	CcSEcCtD
Propranolol—Convulsion—Carmustine—malignant glioma	0.00121	0.011	CcSEcCtD
Propranolol—Cough—Temozolomide—malignant glioma	0.00118	0.0107	CcSEcCtD
Propranolol—Convulsion—Temozolomide—malignant glioma	0.00117	0.0106	CcSEcCtD
Propranolol—HTR1A—brain—malignant glioma	0.00116	0.00743	CbGeAlD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00114	0.0103	CcSEcCtD
Propranolol—Infection—Carmustine—malignant glioma	0.00113	0.0103	CcSEcCtD
Propranolol—Anaphylactic shock—Temozolomide—malignant glioma	0.0011	0.00999	CcSEcCtD
Propranolol—CYP1A1—central nervous system—malignant glioma	0.0011	0.00704	CbGeAlD
Propranolol—Infection—Temozolomide—malignant glioma	0.00109	0.00992	CcSEcCtD
Propranolol—ABCB1—retina—malignant glioma	0.00109	0.00699	CbGeAlD
Propranolol—Nervous system disorder—Temozolomide—malignant glioma	0.00108	0.0098	CcSEcCtD
Propranolol—Skin disorder—Temozolomide—malignant glioma	0.00107	0.0097	CcSEcCtD
Propranolol—Insomnia—Carmustine—malignant glioma	0.00103	0.00935	CcSEcCtD
Propranolol—Paraesthesia—Carmustine—malignant glioma	0.00102	0.00928	CcSEcCtD
Propranolol—Dyspnoea—Carmustine—malignant glioma	0.00102	0.00922	CcSEcCtD
Propranolol—Somnolence—Carmustine—malignant glioma	0.00101	0.00919	CcSEcCtD
Propranolol—ABCB1—telencephalon—malignant glioma	0.00101	0.00643	CbGeAlD
Propranolol—Insomnia—Temozolomide—malignant glioma	0.000996	0.00903	CcSEcCtD
Propranolol—Decreased appetite—Carmustine—malignant glioma	0.00099	0.00899	CcSEcCtD
Propranolol—Paraesthesia—Temozolomide—malignant glioma	0.000989	0.00897	CcSEcCtD
Propranolol—Gastrointestinal disorder—Carmustine—malignant glioma	0.000983	0.00892	CcSEcCtD
Propranolol—Dyspnoea—Temozolomide—malignant glioma	0.000981	0.00891	CcSEcCtD
Propranolol—Somnolence—Temozolomide—malignant glioma	0.000979	0.00888	CcSEcCtD
Propranolol—Constipation—Carmustine—malignant glioma	0.000974	0.00884	CcSEcCtD
Propranolol—Pain—Carmustine—malignant glioma	0.000974	0.00884	CcSEcCtD
Propranolol—Dyspepsia—Temozolomide—malignant glioma	0.000969	0.00879	CcSEcCtD
Propranolol—Decreased appetite—Temozolomide—malignant glioma	0.000957	0.00868	CcSEcCtD
Propranolol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00095	0.00862	CcSEcCtD
Propranolol—Fatigue—Temozolomide—malignant glioma	0.000949	0.00861	CcSEcCtD
Propranolol—Pain—Temozolomide—malignant glioma	0.000941	0.00854	CcSEcCtD
Propranolol—Constipation—Temozolomide—malignant glioma	0.000941	0.00854	CcSEcCtD
Propranolol—Gastrointestinal pain—Carmustine—malignant glioma	0.000932	0.00845	CcSEcCtD
Propranolol—Atomoxetine—SLC6A3—malignant glioma	0.000915	0.055	CrCbGaD
Propranolol—Abdominal pain—Carmustine—malignant glioma	0.000901	0.00817	CcSEcCtD
Propranolol—Body temperature increased—Carmustine—malignant glioma	0.000901	0.00817	CcSEcCtD
Propranolol—Gastrointestinal pain—Temozolomide—malignant glioma	0.0009	0.00817	CcSEcCtD
Propranolol—Carvedilol—PTGS1—malignant glioma	0.000882	0.053	CrCbGaD
Propranolol—Urticaria—Temozolomide—malignant glioma	0.000875	0.00794	CcSEcCtD
Propranolol—CYP1A1—brain—malignant glioma	0.000874	0.00559	CbGeAlD
Propranolol—Body temperature increased—Temozolomide—malignant glioma	0.00087	0.0079	CcSEcCtD
Propranolol—Abdominal pain—Temozolomide—malignant glioma	0.00087	0.0079	CcSEcCtD
Propranolol—Hypersensitivity—Carmustine—malignant glioma	0.000839	0.00762	CcSEcCtD
Propranolol—Asthenia—Carmustine—malignant glioma	0.000817	0.00742	CcSEcCtD
Propranolol—Hypersensitivity—Temozolomide—malignant glioma	0.000811	0.00736	CcSEcCtD
Propranolol—CYP3A4—central nervous system—malignant glioma	0.000807	0.00516	CbGeAlD
Propranolol—CYP2D6—central nervous system—malignant glioma	0.000795	0.00508	CbGeAlD
Propranolol—ABCB1—medulla oblongata—malignant glioma	0.00079	0.00505	CbGeAlD
Propranolol—Asthenia—Temozolomide—malignant glioma	0.00079	0.00717	CcSEcCtD
Propranolol—Diarrhoea—Carmustine—malignant glioma	0.000779	0.00707	CcSEcCtD
Propranolol—CYP2D6—cerebellum—malignant glioma	0.000777	0.00497	CbGeAlD
Propranolol—Dizziness—Carmustine—malignant glioma	0.000753	0.00684	CcSEcCtD
Propranolol—Diarrhoea—Temozolomide—malignant glioma	0.000753	0.00683	CcSEcCtD
Propranolol—Dizziness—Temozolomide—malignant glioma	0.000728	0.00661	CcSEcCtD
Propranolol—Vomiting—Carmustine—malignant glioma	0.000724	0.00657	CcSEcCtD
Propranolol—ABCB1—midbrain—malignant glioma	0.000722	0.00462	CbGeAlD
Propranolol—Rash—Carmustine—malignant glioma	0.000718	0.00652	CcSEcCtD
Propranolol—Dermatitis—Carmustine—malignant glioma	0.000718	0.00651	CcSEcCtD
Propranolol—ABCB1—spinal cord—malignant glioma	0.000705	0.00451	CbGeAlD
Propranolol—Vomiting—Temozolomide—malignant glioma	0.0007	0.00635	CcSEcCtD
Propranolol—Rash—Temozolomide—malignant glioma	0.000694	0.0063	CcSEcCtD
Propranolol—Dermatitis—Temozolomide—malignant glioma	0.000693	0.00629	CcSEcCtD
Propranolol—Nausea—Carmustine—malignant glioma	0.000677	0.00614	CcSEcCtD
Propranolol—Nausea—Temozolomide—malignant glioma	0.000654	0.00593	CcSEcCtD
Propranolol—CYP2D6—brain—malignant glioma	0.000631	0.00403	CbGeAlD
Propranolol—ABCB1—central nervous system—malignant glioma	0.000572	0.00366	CbGeAlD
Propranolol—ABCB1—cerebellum—malignant glioma	0.000559	0.00357	CbGeAlD
Propranolol—ABCB1—brain—malignant glioma	0.000454	0.0029	CbGeAlD
Propranolol—HTR1B—Signaling Pathways—FGF2—malignant glioma	2.79e-05	0.00012	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—IDH1—malignant glioma	2.79e-05	0.00012	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CAV1—malignant glioma	2.77e-05	0.000119	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTT1—malignant glioma	2.77e-05	0.000119	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—NCOR1—malignant glioma	2.77e-05	0.000119	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—FN1—malignant glioma	2.76e-05	0.000119	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—F2—malignant glioma	2.76e-05	0.000119	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.75e-05	0.000118	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—KDR—malignant glioma	2.74e-05	0.000118	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—BAD—malignant glioma	2.73e-05	0.000117	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NOTCH1—malignant glioma	2.7e-05	0.000116	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—FN1—malignant glioma	2.7e-05	0.000116	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—F2—malignant glioma	2.7e-05	0.000116	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SPHK1—malignant glioma	2.7e-05	0.000116	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—BAD—malignant glioma	2.67e-05	0.000115	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—VEGFA—malignant glioma	2.66e-05	0.000115	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PIK3CD—malignant glioma	2.65e-05	0.000114	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CD80—malignant glioma	2.65e-05	0.000114	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.64e-05	0.000114	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PIK3CD—malignant glioma	2.64e-05	0.000114	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	2.64e-05	0.000114	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CG—malignant glioma	2.64e-05	0.000114	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—APC—malignant glioma	2.64e-05	0.000114	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—FN1—malignant glioma	2.64e-05	0.000114	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—F2—malignant glioma	2.64e-05	0.000114	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—STAT3—malignant glioma	2.63e-05	0.000113	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—PIK3CA—malignant glioma	2.62e-05	0.000113	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MDM2—malignant glioma	2.61e-05	0.000112	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGF—malignant glioma	2.61e-05	0.000112	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—BAD—malignant glioma	2.61e-05	0.000112	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—RAF1—malignant glioma	2.6e-05	0.000112	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS1—malignant glioma	2.6e-05	0.000112	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PTPN11—malignant glioma	2.59e-05	0.000112	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CD80—malignant glioma	2.59e-05	0.000111	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.59e-05	0.000111	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	2.58e-05	0.000111	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—APC—malignant glioma	2.58e-05	0.000111	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NOTCH1—malignant glioma	2.58e-05	0.000111	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ERBB2—malignant glioma	2.57e-05	0.000111	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGF—malignant glioma	2.55e-05	0.00011	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PIK3CB—malignant glioma	2.54e-05	0.000109	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PTPN11—malignant glioma	2.54e-05	0.000109	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CD80—malignant glioma	2.53e-05	0.000109	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—APC—malignant glioma	2.53e-05	0.000109	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CG—malignant glioma	2.53e-05	0.000109	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.5e-05	0.000108	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGF—malignant glioma	2.5e-05	0.000107	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—BRAF—malignant glioma	2.48e-05	0.000107	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PTPN11—malignant glioma	2.48e-05	0.000107	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GSTP1—malignant glioma	2.46e-05	0.000106	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MYC—malignant glioma	2.45e-05	0.000105	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CXCL8—malignant glioma	2.44e-05	0.000105	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—BRAF—malignant glioma	2.43e-05	0.000105	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT2—malignant glioma	2.42e-05	0.000104	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—BCHE—malignant glioma	2.41e-05	0.000104	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GSTP1—malignant glioma	2.41e-05	0.000104	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—EGFR—malignant glioma	2.41e-05	0.000104	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CAT—malignant glioma	2.4e-05	0.000103	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—EGFR—malignant glioma	2.39e-05	0.000103	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CAV1—malignant glioma	2.39e-05	0.000103	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.38e-05	0.000103	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—BRAF—malignant glioma	2.37e-05	0.000102	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT2—malignant glioma	2.36e-05	0.000102	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—AKT1—malignant glioma	2.36e-05	0.000102	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—EGFR—malignant glioma	2.35e-05	0.000101	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CAT—malignant glioma	2.34e-05	0.000101	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CASP3—malignant glioma	2.34e-05	0.000101	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL2—malignant glioma	2.33e-05	0.0001	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	2.32e-05	9.99e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT2—malignant glioma	2.31e-05	9.95e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PIK3CB—malignant glioma	2.31e-05	9.93e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PIK3CB—malignant glioma	2.3e-05	9.91e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—EGFR—malignant glioma	2.3e-05	9.9e-05	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	2.3e-05	9.9e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTGS2—malignant glioma	2.28e-05	9.84e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTGS2—malignant glioma	2.28e-05	9.82e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—KRAS—malignant glioma	2.27e-05	9.78e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	2.27e-05	9.77e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTP1—malignant glioma	2.27e-05	9.76e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—NCOR1—malignant glioma	2.26e-05	9.75e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—KRAS—malignant glioma	2.26e-05	9.74e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CAV1—malignant glioma	2.26e-05	9.71e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.25e-05	9.71e-05	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	2.25e-05	9.68e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.23e-05	9.62e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—KRAS—malignant glioma	2.22e-05	9.57e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—FGF2—malignant glioma	2.22e-05	9.57e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	2.22e-05	9.56e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—NCOR1—malignant glioma	2.21e-05	9.52e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MMP9—malignant glioma	2.21e-05	9.51e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CAT—malignant glioma	2.21e-05	9.5e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	2.2e-05	9.47e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PTEN—malignant glioma	2.2e-05	9.45e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.18e-05	9.36e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—FGF2—malignant glioma	2.17e-05	9.36e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—KRAS—malignant glioma	2.17e-05	9.36e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.16e-05	9.28e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—AKT1—malignant glioma	2.14e-05	9.22e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTT1—malignant glioma	2.14e-05	9.2e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—FGF2—malignant glioma	2.13e-05	9.15e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PPARG—malignant glioma	2.1e-05	9.04e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	2.09e-05	8.99e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—NCOR1—malignant glioma	2.08e-05	8.97e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MDM2—malignant glioma	2.08e-05	8.95e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PIK3CA—malignant glioma	2.08e-05	8.95e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RAF1—malignant glioma	2.07e-05	8.92e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CG—malignant glioma	2.06e-05	8.85e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ERBB2—malignant glioma	2.05e-05	8.83e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	2.04e-05	8.79e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MDM2—malignant glioma	2.03e-05	8.76e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RAF1—malignant glioma	2.03e-05	8.73e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	2.02e-05	8.71e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TP53—malignant glioma	2.01e-05	8.65e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ERBB2—malignant glioma	2.01e-05	8.63e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS1—malignant glioma	2e-05	8.63e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	2e-05	8.6e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTEN—malignant glioma	1.99e-05	8.58e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTEN—malignant glioma	1.99e-05	8.56e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MDM2—malignant glioma	1.99e-05	8.56e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PPARG—malignant glioma	1.98e-05	8.54e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—malignant glioma	1.98e-05	8.54e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RAF1—malignant glioma	1.98e-05	8.53e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	1.98e-05	8.52e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—STAT3—malignant glioma	1.96e-05	8.45e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ERBB2—malignant glioma	1.96e-05	8.44e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.95e-05	8.39e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCL8—malignant glioma	1.94e-05	8.37e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	1.94e-05	8.33e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTP1—malignant glioma	1.92e-05	8.27e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.91e-05	8.23e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCL8—malignant glioma	1.9e-05	8.19e-05	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	1.88e-05	8.09e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CAT—malignant glioma	1.87e-05	8.04e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—BCHE—malignant glioma	1.86e-05	8.02e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CASP3—malignant glioma	1.86e-05	8.01e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCL8—malignant glioma	1.86e-05	8.01e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL2—malignant glioma	1.86e-05	8e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CAV1—malignant glioma	1.85e-05	7.95e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.84e-05	7.92e-05	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	1.84e-05	7.91e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MYC—malignant glioma	1.82e-05	7.85e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CASP3—malignant glioma	1.82e-05	7.84e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL2—malignant glioma	1.82e-05	7.82e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.81e-05	7.78e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CAV1—malignant glioma	1.8e-05	7.76e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	1.8e-05	7.73e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EGFR—malignant glioma	1.78e-05	7.68e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CASP3—malignant glioma	1.78e-05	7.66e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL2—malignant glioma	1.78e-05	7.65e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NCOR1—malignant glioma	1.76e-05	7.6e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.76e-05	7.59e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MMP9—malignant glioma	1.76e-05	7.57e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PTEN—malignant glioma	1.75e-05	7.53e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MMP9—malignant glioma	1.72e-05	7.41e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PTEN—malignant glioma	1.71e-05	7.36e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AKT1—malignant glioma	1.71e-05	7.34e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CAV1—malignant glioma	1.7e-05	7.31e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AKT1—malignant glioma	1.7e-05	7.31e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—KRAS—malignant glioma	1.69e-05	7.26e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MMP9—malignant glioma	1.68e-05	7.24e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.68e-05	7.24e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PTEN—malignant glioma	1.67e-05	7.2e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AKT1—malignant glioma	1.67e-05	7.18e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.67e-05	7.18e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTGS2—malignant glioma	1.65e-05	7.11e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CG—malignant glioma	1.64e-05	7.07e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AKT1—malignant glioma	1.63e-05	7.02e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPARG—malignant glioma	1.62e-05	6.99e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPARG—malignant glioma	1.58e-05	6.82e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—malignant glioma	1.58e-05	6.8e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.57e-05	6.78e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STAT3—malignant glioma	1.56e-05	6.73e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTGS2—malignant glioma	1.56e-05	6.72e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	1.55e-05	6.67e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.55e-05	6.66e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—malignant glioma	1.54e-05	6.65e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STAT3—malignant glioma	1.53e-05	6.58e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—malignant glioma	1.51e-05	6.5e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TP53—malignant glioma	1.5e-05	6.45e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STAT3—malignant glioma	1.5e-05	6.44e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPARG—malignant glioma	1.49e-05	6.43e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTP1—malignant glioma	1.48e-05	6.38e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.48e-05	6.36e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MYC—malignant glioma	1.45e-05	6.25e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CD—malignant glioma	1.44e-05	6.21e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CAT—malignant glioma	1.44e-05	6.21e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTEN—malignant glioma	1.44e-05	6.2e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CAV1—malignant glioma	1.44e-05	6.19e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MYC—malignant glioma	1.42e-05	6.12e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGFR—malignant glioma	1.42e-05	6.12e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.41e-05	6.05e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PIK3CA—malignant glioma	1.4e-05	6.04e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGFR—malignant glioma	1.39e-05	5.98e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MYC—malignant glioma	1.39e-05	5.98e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.37e-05	5.92e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NCOR1—malignant glioma	1.36e-05	5.86e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTEN—malignant glioma	1.36e-05	5.86e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.36e-05	5.85e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGFR—malignant glioma	1.36e-05	5.85e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—KRAS—malignant glioma	1.34e-05	5.78e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—KRAS—malignant glioma	1.31e-05	5.65e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.31e-05	5.64e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.29e-05	5.55e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—KRAS—malignant glioma	1.28e-05	5.53e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTGS2—malignant glioma	1.28e-05	5.5e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AKT1—malignant glioma	1.27e-05	5.45e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARG—malignant glioma	1.26e-05	5.44e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CB—malignant glioma	1.26e-05	5.41e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTGS2—malignant glioma	1.25e-05	5.37e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	1.23e-05	5.31e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	1.21e-05	5.19e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TP53—malignant glioma	1.19e-05	5.14e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.19e-05	5.1e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	1.18e-05	5.08e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTGS2—malignant glioma	1.17e-05	5.06e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TP53—malignant glioma	1.17e-05	5.02e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.15e-05	4.96e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AKT1—malignant glioma	1.15e-05	4.94e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AKT1—malignant glioma	1.15e-05	4.94e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TP53—malignant glioma	1.14e-05	4.91e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTEN—malignant glioma	1.11e-05	4.79e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CAV1—malignant glioma	1.11e-05	4.78e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTEN—malignant glioma	1.09e-05	4.68e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTEN—malignant glioma	1.02e-05	4.41e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.02e-05	4.37e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.01e-05	4.35e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT1—malignant glioma	1.01e-05	4.34e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CB—malignant glioma	1e-05	4.32e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS2—malignant glioma	9.95e-06	4.28e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT1—malignant glioma	9.86e-06	4.24e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARG—malignant glioma	9.76e-06	4.2e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT1—malignant glioma	9.64e-06	4.15e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CA—malignant glioma	9.6e-06	4.13e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CD—malignant glioma	8.89e-06	3.83e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTEN—malignant glioma	8.68e-06	3.74e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AKT1—malignant glioma	8.3e-06	3.57e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CA—malignant glioma	7.86e-06	3.38e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AKT1—malignant glioma	7.84e-06	3.38e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CB—malignant glioma	7.75e-06	3.34e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS2—malignant glioma	7.68e-06	3.31e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CA—malignant glioma	7.67e-06	3.3e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CA—malignant glioma	7.23e-06	3.11e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTEN—malignant glioma	6.7e-06	2.88e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AKT1—malignant glioma	6.42e-06	2.76e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AKT1—malignant glioma	6.26e-06	2.7e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CA—malignant glioma	6.12e-06	2.64e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AKT1—malignant glioma	5.9e-06	2.54e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AKT1—malignant glioma	5e-06	2.15e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.72e-06	2.03e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKT1—malignant glioma	3.86e-06	1.66e-05	CbGpPWpGaD
